Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
NCT00298662
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Interferon beta-1b and Tacrolimus
Sponsor
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais